Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers
- 19 January 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 53 (3), 201-207
- https://doi.org/10.1016/j.jcv.2011.12.010
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Impact of Varicella Vaccine on Varicella-Zoster Virus DynamicsClinical Microbiology Reviews, 2010
- Chickenpox in adults – Clinical managementJournal of Infection, 2008
- Varicella and the pregnant woman: Prevention and managementAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2008
- Performance of a Time-Resolved Fluorescence Immunoassay for Measuring Varicella-Zoster Virus Immunoglobulin G Levels in Adults and Comparison with Commercial Enzyme Immunoassays and Merck Glycoprotein Enzyme ImmunoassayClinical and Vaccine Immunology, 2006
- Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality dataBMJ, 2001
- Varicella Vaccine — The First Six YearsNew England Journal of Medicine, 2001
- Varicella-zoster virusClinical Microbiology Reviews, 1996
- Current status and prospects of live varicella vaccineVaccine, 1992
- Antibody assays suitable for assessing immune responses to live varicella vaccineVaccine, 1991
- Natural and artificial immunity to varicella zoster virusJournal of Medical Virology, 1988